Although IL-6 has been identified as a major growth factor in ied.
Introduction

Materials and methods
The growth and survival of myeloma cells within the bone Clinical background marrow is believed to be regulated by functional interactions between the tumor cells and the surrounding bone marrow The MM5 cell line is derived from bone marrow of a 55-yearstroma, including the action of various cytokines. Within this old male who was diagnosed in October 1992 as MM stage regulatory network, interleukin-6 (IL-6) has been identified as IIIA. At the time of diagnosis, an iliac crest bone marrow aspirthe major tumor stimulating factor. IL-6 stimulates the proliferate showed 28% plasma cells which upon immunocytoation of malignant plasma cells in vitro and this dependence plasmic staining showed IgA (29%) or light chain only in vitro correlates with the myeloma cell proliferation in (71%). Serum electrophoresis revealed an IgA-M-compovivo. 1, 2 However, the growth-stimulative effect of IL-6 in vitro, nent while free monoclonal chain was detected in both is only observed in approximately 50% of the patients studserum and urine. One month later a new marrow aspirate showed 21% plasma cells of which 50% expressed cytoplasmic IgA and 50% IgG. At this moment an additional Mcomponent (IgG) became detectable in the serum. Between treatment cycles with vincristine, doxorubicin and dexameBelgium); HLA DR expression was examined using an own produced monoclonal antibody. 17 thasone resulting only in a partial response. At the end of February 1993, disease progression was observed. Bone marrow The presence of surface and cytoplasmic immunoglobulins was examined using rabbit F(ab) 2 antisera recognizing human plasma cells were now all IgA positive while serum electrophoresis only revealed an IgA paraprotein. At that time, the Ig isotypes (␣, ␥, ␦, , ⑀, , ) directly labeled with FITC (Dako; Prosan, Ghent, Belgium). The distribution of intracellupatient received local radiotherapy for 1 month followed by monotherapy with high-dose dexamethasone. In May 1993, lar Ig isotypes was determined after fixation and staining of cells, sedimented on cytocentrifuge slides, as reported prethe patient died of resistant disease.
viously. 18 Cells were evaluated by fluorescence microscopy. For EBV nuclear antigen (EBNA) staining, cultured cells were cytocentrifuged on glass slides, fixed with 70% ethanol for Culture conditions 10 min and stained with EBV-CS1-4, a monoclonal antibody derived from Novocastra Laboratories (Prosan). To determine Myeloma cells were obtained from the patient's bone marrow the expression of the IL-6 receptor (gp80) and the transducer during clinical relapse, in February 1993. The marrow aspirate chain gp130, MM5.1 and MM5.2 cells were labeled with was mixed with hydroxy-ethyl starch (HES) at a ratio 3:7 (vol the monoclonal antibodies B-N12 (gp80), B-R3 (gp130) HES:vol cell suspension) and allowed to sediment for 30 min.
(Diaclone, Besançon, France) and a negative control antibody. Buffy coat cells were collected, washed twice in RPMI 1640
A FITC-conjugated rabbit anti-mouse Ig antiserum (Dako) was medium and finally suspended in RPMI 1640 supplemented used as second step reagent and the cells were finally with 10 −6 m hydrocortisone (Sigma, NTL, Brussels, Belgium), analyzed by FACS (Coulter Epics XL). As positive control we 12.5% horse serum (Life Technologies, Ghent, Belgium), used the U266 cell line which was shown to express the IL-12.5% fetal calf serum (Elscolab, Kruibeke, Belgium), 1% pen-6 receptor. 19 icilline, 1% streptomycin and 1% glutamine (Life Technologies). The cells were cultured in 25 cm 2 tissue culture flasks at a starting concentration of 2 × 10 6 /ml and at
Cell growth analysis 37°C in 5% CO 2 in air. The cultures were fed twice a week by aspiration and replacement of half of the spent media. For MM5.1 cells were cultured in a 96-well plate, at a density of long term propagation of the obtained cell line, bone marrow 2 × 10 3 cells/well for a period of 7 days with different concensamples of normal donors were cultured using the same prototrations of various cytokines or with serially diluted concol. After reaching confluency, the normal stromal cell-layers ditioned medium (CM) obtained from marrow fibroblasts, culwere trypsinized and passaged three times to eliminate most tured with or without MM5.1 cells and from the cell lines hematopoietic cells. Prior to the addition of MM5.1 cells the AA101 and LP101. Conditioned media were collected 3 days stromal cell layers were irradiated at 1500 rad and hydrocortiafter medium change. AA101 and LP101 are two bone marsone-free medium was added.
row stromal cell lines that were established by transfection with a recombinant SV40-adenovirus vector. 20 AA101 shows fibroblastic characteristics while LP101 seems to be of macrophage origin. Both cell lines produce detectable amounts of Light and electron microscopy (Ref 20 and own observations). 20 IL-6, IL-10, IL-11, SCF, OSM, LIF were obtained from Genzyme (Ghent, Belgium). Cytospins were stained by May-Grünwald-Giemsa and evaluCell proliferation was analyzed by culturing cells with or withated by light microscopy. For electron microscopy, the cells out cytokines or CM for 6 days, followed by 18 h culture with were fixed, embedded and stained according to routine 3 H thymidine. Cells were harvested and tritium incorporation methods. Briefly, the cells were fixed with 1% glutaraldehyde, was determined. All experiments were performed in triplicate. treated with osmiumtetroxide and stained with uranyl acetate.
In addition cells were also cultured in 24 well plates at a denThey were dehydrated and embedded in epon. Thin sections sity of 2 × 10 4 /well for 21 days and growth was evaluated by were stained with lead citrate and examined by electron counting the weekly output of viable cells as measured by microscopy.
trypan blue exclusion. To determine the possible involvement of IL-6 in the growth of MM5 cells, cell proliferation in the presence of CM from marrow fibroblasts was evaluated after
Immunophenotyping adding various concentrations of a neutralizing anti-human IL-6 antiserum (Life Technologies) and a neutralising anti-gp130 The phenotype of MM5 cells was examined by immunogoldantibody, kindly provided by J Wijdenes (Diaclone). As negasilver staining. Non-adherent cells were labeled in suspension tive controls for the neutralizing antisera we used an isotypeas described earlier. 15 Adherent cells were stained in situ after matched monoclonal antibody and affinity-purified rabbit being cultured with bone marrow stromal cells on coverslides.
antiserum against a murine paraprotein (kindly provided by Therefore a previously described procedure was used. 16 The Prof K Thielemans, Free University Brussels). In some experifollowing monoclonal antibodies were used: CD10, CD20, ments, cell proliferation was also evaluated after preventing CD21 from Coulter (Analis, Namur, Belgium); CD19, CD38, direct cell to cell contact between MM5 cells and cultured CD3, CD4, CD8, CD16, CD56, CD45 from Becton Dickinson stromal cells, using transwell inserts (Falcon, Belgium Apoptosis determination microliters of PCR mixture were subjected to electrophoresis through a 1% agarose/TBE gel, transferred and cross-linked to To determine the occurrence of apoptosis in MM5.1 cells, that are not exposed to stromal factors, DNA fragmentation was a nylon membrane (Fluka, Sigma) . The filter was hybridized to a 32 P-labelled LIFR␤-specific cDNA probe (kindly provided determined by agarose gel electrophoresis. One million cells were centrifuged at 200 g, and the pellet was resuspended in by Prof R Bataille, Institute of Biology, Nantes). TE buffer (10 mm Tris-HCl, 1 mm EDTA) containing 0.2% Triton X 100. After centrifugation at 13 000 g, the supernatant was transferred to another tube. The pellet was resuspended Cloning and sequencing of the amplified fragments from the V L segment in 0.5 ml TE buffer and 0.1 ml cold 5m NaCl was added to both tubes. DNA was precipitated with isopropanol at −20°C. After centrifugation at 13 000g, the supernatant was removed PCR products were ligated into pCRII vectors and transformed into INV␣F′ cells using the TA Cloning Kit (Invitrogen, Leek, and the DNA pellets were washed in 70% EtOH and air-dried. Finally, the DNA pellets were resuspended in 30 l TE buffer, The Netherlands). Starting from minicultures of the recombinant clones, the DNA was extracted using the Wizard Miniincubated for 2 h at 37°C and heated at 65°C for 10 min. Twenty-five microliters were mixed with loading buffer and preps DNA Purification System (Promega, Leiden, The Netherlands). The sequences were determined making use of loaded per well on a 1% agarose gel. Bands were visualized by staining with ethidium bromide.
the Sequenase Version 2.0 DNA Sequencing Kit (Amersham, Ghent, Belgium).
Nucleic acid preparations
Results Total RNA and DNA were extracted using the TRIzol reagent (Gibco, Life Technologies) from quick frozen cell pellets and Establishment of the MM5.1 cell line from frozen stored cytospins containing bone marrow cells from the same sample that was used to establish the culture.
A bone marrow sample, collected in February 1993, was cultured in standard conditions. After 3-4 weeks a confluent For the PCR analyses on RNA, 1-5 g of total RNA was converted into first strand cDNA, using the Superscript Preampliadherent cell layer became detectable. In association with the stromal cells, small round hematopoietic cells could be fication System (Gibco, Life Technologies).
observed, mostly organized in small aggregates. These hematopoietic cells remained present over time and even started to increase in number, a few weeks later. This observation Southern blot analyses contrasted with the evolution of other myeloma long-term cultures in which hematopoietic cells diminished tremendously Ten micrograms of genomic DNA were digested with BglII and with PstI. After electrophoretic separation in 0.8% agarose after 7 weeks (own observation). As culture progressed, a proportion of the growing cells detached from the stromal layer and alkaline denaturation according to standard procedures, the DNA was transferred to nylon membranes (Fluka, Sigma, and became detectable in the culture supernatant as floating cell aggregates. Morphological analysis at 2 months of culture, Bornem, Belgium) in 20 × SSC and cross-linked by a short UV exposure followed by 2 h of baking at 80°C. Hybridization revealed that all hematopoietic cells in both the adherent and non-adherent compartment, showed a plasmacytic nature with the JH probe 21 was performed overnight in 2 × SSC/1% SDS/5 × Denhardt's solution/200 g/ml salmon sperm DNA at ( Figure 1 ). When non-adherent cells were transferred on to 65°C. Post-hybridization washes were performed in 0.2 × SSC/0.1% SDS at 65°C. The probe was radioactive labeled by random primed DNA elongation.
PCR analyses
For the Ig light chain (V L ) analysis on RNA, a PCR was performed on first strand cDNA, making use of an antisense Ck primer (5′ acg gga tcc cag atg gcg gga aga tg 3′), in combination with a sense V LLeadere primer (5′ ggg ggc gcg cca tgg aa(a,g) ccc cag c 3′). PCR cycles (40) were applied after a 5′ incubation at 95°C with the following steps: 30 s at 95°C, 30 s at 40°C and 1 min 20 s at 72°C. Finally, the program ended with an incubation at 72°C for 10 min.
For detection of LIFR␤ mRNA in both variants, a PCR was performed on cDNA using the following primers: RH1(5′CGGATCCAGGACTGCATTGCAC) and RH2
Figure 1
Electron micrograph showing a MM5.1 (9 000 X).
(5′AACAGCTGTTGAATTAATATCCTTC) (manufactured by When growth of MM5.1 cells was evaluated in a culture
allowing direct cellular contact with bone marrow stroma vs marrow stromal cells was 12 860 pg/ml. The IL-6 concen-
Figure 4
MM5.1 cells were cultured in 24-well plates at a density of 2 × 10 4 cells/cup in the presence of a stromal marrow cell-layer with and without a transwell insert. As a control, cells were also cultured in the presence of culture medium and without stroma. At days 7 and 14 the output of viable, non-adherent tumor cells was determined by trypan blue exclusion. the corresponding control antisera had no effect (Figure 7 ). When MM5.1 cells were cultured with IL-6 + soluble gp80 a strong proliferative effect was noticed in a dose-dependent manner (Figure 8 ). Using a quantitative immunoassay, no soluble gp80 could be detected in stromal supernatants.
Detection of DNA degradation in MM5.1 cells
To verify the hypothesis that cell death in MM5.1 cells, not exposed to stromal factors, occurs by apoptosis, genomic DNA was prepared from equal numbers of cells cultured for 6 and 24 h with and without bone marrow stroma. Agarose gel electrophoresis of this DNA demonstrated the typical oligonucleosomal fragmentation pattern of apoptotic cell death only in cells cultured without bone marrow stroma ( Figure 9) . A similar result was obtained when MM5.1 cells were cultured for 24 h with exogeneous IL-6 (data not shown). After more than 1 year in culture, a variant of the cell line could be obtained that grows stroma independently (MM5.2) tration in the supernatant of the LP101 and AA101 cell lines was 77 800 and 186 pg/ml, respectively. When we evaluated ( Figure 10 ). These cells express a more immature morphology than MM5.1 cells and show a plasmablastic aspect. Immunolong-term proliferation of MM5.1 cells, CM of marrow stromal cells gave a consistent increase of viable cells up to 21 days phenotypic analysis could not reveal particular differences in expression of B cell differentiation markers or adhesion molwhile the other conditioned media had no effect (Figure 5b ). When we tested the responsiveness of MM5.1 cells against ecules between the two variants. Similar to the early passage form, MM5.2 cells were negative for the EBV nuclear antigen. individual cytokines, only OSM stimulated the proliferation of MM5.1 cells while LIF, SCF, IL-6, IL-10 and IL-11 had no By Southern blot analysis we found a clonal identity between both cell lines. Figure 11 shows the result of the hybridization effect (Figure 6a of different combinations of IL-3 (100 ng/ml), IL-6 (100 ng/ml), G-CSF (100 ng/ml) and GM-CSF (100 ng/ml) (b). Cells were incubated for 7 days and cell proliferation was measured by thymidine incorporation.
Discussion nation of cells from the stromal compartment on which these cells are grown. In order to prove that the MM5.1 cell lines really originated from the myeloma cells present in the BM of
The growth of myeloma cells is believed to be mediated by functional interactions between the tumor cells and the marthe patient, sequence analysis of the expressed Ig was performed. As the cell lines expressed cytoplasmic chain only, row environment involving the action of several cytokines of which IL-6 has been identified as the most important one. we tried to amplify the variable Ig light chain region (VL) on cDNA from both MM5 variants and the patient's BM. A PCR Although IL-6 has been demonstrated to be directly involved in the myeloma cell proliferation in vitro and in vivo, it is with a V L LEADER primer in combination with a C primer revealed an identical monoclonal V L sequence in all samples.
clear that this cytokine is not the only factor that mediates the proliferation and survival of myeloma cells. In this study we No particular differences in surface expression of the gp130 transducer chain and IL-6 receptor gp80 were found between report on the establishment and characterization of a new human myeloma cell line, MM5.1, of which the long-term MM5.1 and MM5.2 cells (Figure 3 ). PCR amplification revealed in both variants the expression of LIFR␤ mRNA proliferation is dependent on the presence of bone marrow stroma. A considerable number of human myeloma cell lines (Figure 12 ). DNA fragmentation in MM5.1 cells cultured with bone marrow stroma (lanes A and B) and without bone marrow stroma for 6 h (lanes C and D) and 20 h (lanes E and F). For all samples, intact DNA was precipitated and loaded on gel (lanes A, C and E). After precipitation the supernatant was also loaded on gel (lanes B, D and F) to detect eventual smaller DNA fragments. Both, not-fragmented DNA (A, C and E) and smaller DNA fragments (B, D and F) were resolved by agarose gel electrophoresis.
Figure 7
Effect of an anti-IL-6 antiserum and an anti-gp130 mAb on MM5.1 cell proliferation in the presence of stromal supernatant. As negative controls an affinity-purified rabbit antiserum and a monoclonal antibody against a murine paraprotein were used. Each value represents the mean of triplicate cultures.
Figure 10
Comparison between growth behavior of MM5.1 cells and MM5.2 cells in the absence of a stromal cell layer. Cells were cultured in 24-well plates at a density of 2 × 10 4 cells/cup with 10% FCS in RPMI 1640. At days 7, 14 and 21 the output of viable tumor cells was determined by trypan blue exclusion.
Figure 8
MM5.1 cells were cultured with different concentrations of soluble (s)gp 80 and IL-6 (100 ng/ml). Cells were incubated for 7
we observed that MM5.1 cells, not exposed to marrow stroma, days and cell proliferation was measured by thymidine incorporation.
enter into apoptosis after a few hours. Recently, IL-6 has been identified as a cytokine that can prevent apoptosis in different target cell types. 24 ,25 IL-6 can protect myeloma cell lines from have been established previously by other investigators and the reports are too numerous to cite individually. Among these apoptosis induced by serum starvation or dexamethasone treatment. 26, 27 Early myeloma plasma cells were shown to be cell lines, the majority has been derived from peripheral blood or pleural effusions of patients with advanced disease.
protected from apoptosis in vitro when cultured with IL-6.
28
However, this protective effect occurred only in some cells Although a number of myeloma cell lines has been derived from bone marrow samples, the general experience is that in and was detected for only a few days. This makes it likely that IL-6 cannot suppress apoptosis completely, but rather intervitro growth of myeloma cells from bone marrow is much more difficult. Most established myeloma cell lines proliferate feres by delaying its onset. When our cell line was incubated with IL-6 for 24 h, we also found that susceptibility to in an apparently autonomous fashion. After the discovery that IL-6 acts as a growth factor for myeloma cells, an increasing apoptosis could not be prevented. Recently, effects of cytokines that use the same gp130 transnumber of IL-6 dependent myeloma cell lines have been established. [14] [15] [16] 22, 23 However, a continued provision of IL-6 ducer chain as IL-6, on the proliferation of human plasmacytoma cells and myeloma cell lines have been reported. 4 We or conditioned medium from two IL-6 secreting stromal cell lines, did not support the growth of our cell line. Moreover, found that our line is also responsive for oncostatin M but we failed to demonstrate any effect of LIF or IL-11. Responsiveness to oncostatin M was found to correlate to the expression of LIFR␤ mRNA as reported earlier for two other myeloma cell lines. 4 A sustained proliferation could be obtained when MM5.1 cells were cultured in conditioned medium from stromal fibroblasts. Interestingly, the growth-stimulative effect of stromal conditioned medium could be inhibited by the addition of neutralizing antibodies against IL-6 and the gp130 chain. This indicates that MM5.1 cells are responsive to IL-6 only when exposed to one or more additional factor(s) provided by the marrow stroma. In previous reports it has been demonstrated that myeloma cells show an increased proliferation when IL-6 is combined with IL-3, G-CSF or GM-CSF. [29] [30] [31] Moreover, it has been reported that human myeloma cell lines can be reproducibly obtained when fresh extramedullary tumor cells are cultured in the presence of IL-6 and GM-CSF. 32 However, our line did not show an increased proliferation when MM5.1 cells were cocultured with combinations of IL-6, G-CSF and GM-CSF. Despite the apparent involvement of IL-6 in the growth of MM5.1 cells, we failed to demonstrate a significant expression of the IL-6 receptor (gp80) on the surface of the cells when they were cocultured with bone marrow stroma. This observation is consistent with the finding of Lasfar et al 33 who found a down-regulation of membrane IL-6 receptors on the myeloma cell line XG1 in the presence of IL-6, although this line is completely IL-6 dependent for its growth. This may indicate that a low number of surface gp80 molecules (even under the detection limit in FACS analysis) might be sufficient to mediate IL-6 signal transduction. Villunger et al 34 observed recently that some myeloma cell lines express the ligand binding domain of the IL-6 receptor although surface gp80 expression remains under the threshold of detection when several monoclonal antibodies are used against epitopes different from the IL-6 binding site. Therefore,
Figure 11
Rearrangement of immunoglobulin heavy chain genes in MM5.1 and MM5.2 cells, cultured with (w) and without (w/o) bone we cannot exclude that the failure to detect membrane gp80 marrow stroma. Southern blot analysis was performed utilizing a JH on MM5 cells is due to the nature of the antibody used.
probe and after digestion with BglII and PstI. Germline bands (GL) A striking finding was the strongly elevated proliferation in and rearranged bands (R) are indicated.
the presence of IL-6 and soluble IL-6 receptor (sgp80). To test the hypothesis that sgp80 is released by marrow stromal cells, conditioned medium of stromal cells was analyzed by ELISA but no soluble receptor could be detected. This implies that at least one other, thus far unidentified, stroma-derived factor provides a crucial co-signal for IL-6 to stimulate cell proliferation and/or to prevent apoptosis. Candidate molecules, involved in this process may be already known growth-promoting factors, novel cytokines or possible other stromaderived molecules, such as extra cellular matrix (ECM) components. Studies using additional defined cytokines and ECM components are underway to determine if thus far untested factors can explain the supportive function of stromal conditioned medium. In addition, stromal supernatants fractionated by ultra-filtration and/or ion exchange chromatography will also be tested for growth-promoting and/or apoptosispreventing effects on MM5.1 cells.
After more than 1 year in continuous culture, the original cell line showed an improved growth rate and development of stroma independency was noticed. This resulted in the generation of a complete stroma-independent variant (MM5.2). Sequencing of the expressed light chain RNA confirmed that both variants were derived from the original tumor cells. To
Figure 12
Detection of LIFR-␤ mRNA expression in the MM5 variour knowledge only two myeloma cell lines (U266 and HL ants and L363 cells by PCR. After electrophoresis through a 1% aga-407) have been described so far, of which both a paracrine rose gel, the amplified material was transferred and crosslinked to a and autocrine growing form exist. 35, 36 In both lines, developnylon membrane and finally hybridized to the LIFR-␤ probe. After ment of autocrine growth behavior was associated with endoautoradiography, the most intensive band, present in all samples, corresponds to the expected fragment of 1.35 kb.
geneous IL-6 production. On the other hand, most auto-
